Product Detail

Name: Eptifibatide  

Feature: 

Integrin is a new type of peptide platelet glycoprotein Ⅱ b/Ⅲ a receptor antagonist, which inhibits platelet aggregation and thrombosis through the last common way of inhibiting platelet aggregation.

Compared with the monoclonal antibody abciximab, etibalide has stronger binding to GP Ⅱ b/Ⅲ a, more directivity and specificity due to the existence of a single conservative amino acid substitution-lysine instead of arginine.

Therefore, it should play a good role in the interventional treatment of acute coronary syndrome.

Composition:

Assay: 99%

Appearance: White powder

CAS No. 188627-80-7

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.